Cardia Bioplastics Limited is a global developer, manufacturer and marketer of resins. The Company's operates in three segments: Manufacturing Division, which develops and manufactures resins derived from renewable resources for the global packaging and plastic products industries; Distribution Division, which includes the Company's distributors in Australia, Americas, Europe, and Asia, and Corporate Division, which is engaged in manufacturing and distribution divisions on financial, administrative and legal matters and also holds and manages portfolio of investments and interests held or acquired by the Company. It operates in five business units: Environmental Technology, Biotechnology Medical, Biotechnology Agricultural, Natural Pharmaceuticals and Mineral Exploration.

Sales Analysis. Sales increased substantially in 2012: Cardia Bioplastics Limited reported sales of A$4.30 million (US$4.26 million) for the fiscal year ending June of 2012. This represents an increase of 160.8% versus 2011, when the company's sales were A$1.65 million. Sales of Distribution saw an increase of 227.3% in 2012, from A$798,279.00 to A$2.61 million. Business Description